🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Recruitingn/aAges 18 Years - 65 YearsAllThird Affiliated Hospital, Sun Yat-Sen University
NCT04310787 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age from 18 to 65 years old; * The diagnosis consistent with hepatitis b associated chronic acute liver failure； * After hospitalization, the survival time \> 90 days； * The inpatient clinical data are complete. Exclusion Criteria: * Human immunodeficiency virus infection or congenital immune deficiency diseases; * Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival; * Other conditions that the researchers judged not appropriate for inclusion.
💊

What it tests

  • Not listed
📍

Where

1 site
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy